How Big Business and the Medical Establishment Are Corrupting the Fight Against AIDS
Good Intentions is a tale of vaulting ambition, greed, and hubris set against the tragic backdrop of AIDS.
Bruce Nussbaum takes us behind the scenes to reveal how America's top scientists are at the center of a triangle of power. He shows how the National Institute of Health allied with the drug company Burroughs Wellcome, secretly helped by the FDA, to steamroll a thirty-year-old drug, AZT, into becoming the only approved treatment for AIDS.
An old-boy network of powerful medical researchers dominates in every disease field, from AIDS to Alzheimer's, Nussbaum reports. They control the major committees, they run the most important trials. They are accountable to no one. Despite the billions of taxpayers' dollars that go to them every year, there is no public oversight. Medical scientists have convinced society that only they can police themselves.
Business Week senior writer Bruce Nussbaum follows the money trial from the billions appropriated by Congress through a network of government laboratories and into the profit statements of Burroughs Wellcome. This is an inside look at how politics, science, and big business are bungling the fight against AIDS.
(The Atlantic Monthly Press, New York, 1990)
This is a recent discovery of an ageless 1995 article, that has become more, rather than less timely with age:
Michael Tracey, Colorado University
Mere smoke of opinion: Aids and the Making of the Public Mind
(Inaugural lecture of the Chair of International Communication,
University of Salford, England UK, 1995)
Kary Mullis, Nobel
Prize winner in Chemistry
Introduction for the book "Inventing
the AIDS Virus"
by Peter Duesberg ( Regnery Publishing, Inc, Washington, DC, 1996)
Serge Lang, Yale University
The Case of HIV and AIDS
The Gallo Case
The two preceding references are from the book
"Challenges" by Serge Lang
(Springer-Verlag, 1998) ISBN 0-387-94861-9
The Case of HIV: We Have Been Misled
from Yale Scientific, Spring 1999